查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1577452

Iodine-131 同位素市场：按应用、最终用户、形式、治疗程序、患者人口统计 - 2025-2030 年全球预测

Iodine-131 Isotope Market by Application (Agricultural, Industrial, Medical), End User (Agricultural Sector, Hospitals and Clinics, Pharmaceutical Companies), Form, Therapeutic Procedures, Patient Demographics - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

碘131同位素市场2023年估值为52亿美元，预计到2024年将达到55.2亿美元，复合年增长率为6.48%，预计到2030年将达到80.7亿美元。

Iodine-131 是一种放射性同位素，广泛用于医疗应用，特别是用于核子医学的诊断和治疗目的。由于其能够选择性破坏组织，因此可用于治疗甲状腺疾病，例如甲状腺功能亢进症和某些类型的甲状腺癌。在能源领域，Iodine-131 也用作水力压裂和逆流诊断的示踪剂。碘131市场的推动因素包括全球甲状腺疾病盛行率的不断上升、人们对核医学的认识和采用的提高以及放射性製药技术的进步。成长的推动因素是医疗基础设施投资的增加和老年人口的增加，而老年人口更容易患甲状腺疾病。此外，对微创治疗的需求不断增长也有助于市场扩张。最近的商业机会包括靶向放射性药物治疗的技术创新，这些创新允许将碘 131 用于治疗其他癌症类型，同时改进递送机制以提高疗效，并减少副作用。然而，严格的法律规范、高製造成本以及由于材料的放射性而需要特殊处理和处置程序等挑战可能会阻碍成长前景。供应链限制以及生产中对一致品质标准的需求也产生了限制。为了抓住市场机会，研究机构和放射性製药公司之间开拓策略合作非常重要。需要技术创新的领域包括研究碘131的新载体分子、提高剂量准确性以及扩大甲状腺相关疾病以外的应用范围。市场是动态的，其特点是技术快速进步和不断变化的治疗需求。这些共同强调了持续研究投资和监管合规对于维持竞争优势和市场渗透的重要性。

主要市场统计
基准年[2023] 52亿美元
预测年份 [2024] 55.2亿美元
预测年份 [2030] 80.7亿美元
复合年增长率（%） 6.48%

市场动态：快速发展的碘 131 同位素市场的关键市场洞察

碘 131 同位素市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大核子医学成像技术在使用碘 131 诊断和治疗各种癌症的应用
    • 加强医疗保健和研究机构之间的合作，促进碘 131 的治疗用途
    • 透过将碘131同位素应用扩展到肿瘤学以外的医学领域来促进市场成长
  • 市场限制因素
    • 发展中地区缺乏先进的医疗设施和训练有素的碘 131 应用专业人员
  • 市场机会
    • 碘 131 同位素在兽医学和动物健康领域的成长潜力研究
    • 新兴市场甲状腺疾病治疗方案中碘 131 同位素采用的评估
    • 探讨碘 131 同位素在创新核医治疗的应用
  • 市场挑战
    • 与替代诊断和治疗同位素的竞争

波特五力：驾驭碘 131 同位素市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解碘 131 同位素市场的外部影响

外部宏观环境因素在影响碘 131 同位素市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解碘131同位素市场的竞争状况

对碘 131 同位素市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵碘 131 同位素市场供应商的绩效评估

FPNV定位矩阵是评估碘131同位素市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划碘 131 同位素市场的成功之路

碘 131 同位素市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 使用碘 131 越来越多地采用核成像技术来诊断和治疗各种癌症
      • 加强医疗保健和研究机构之间的合作，推进碘 131 的治疗用途
      • 碘 131 同位素的应用范围从肿瘤学扩展到其他医学领域，推动市场成长
    • 抑制因素
      • 发展中地区缺乏先进的医疗设施和训练有素的专业人员来应用碘 131
    • 机会
      • 碘131同位素在兽医学和动物健康领域的成长潜力研究
      • 评估新兴市场甲状腺疾病治疗通讯协定中碘 131 同位素的采用情况
      • 考虑在创新核子医学治疗中使用碘 131 同位素
    • 任务
      • 与替代诊断和治疗同位素的竞争
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 碘 131 同位素市场：依应用分类

  • 农业
    • 害虫防治
    • 土壤肥力调查
  • 产业
    • 诊断
    • 放射治疗
  • 药品
    • 甲状腺功能亢进的治疗
    • 研究与开发
    • 甲状腺癌的治疗
  • 製药
    • 放射性药物

第 7 章 碘 131 同位素市场：依最终用户分类

  • 农业领域
  • 医院和诊所
    • 私立医院
    • 公立医院
  • 製药公司
  • 调查机构
    • 学术研究所
    • 医学研究机构

第八章 碘 131 同位素市场：依形式

  • 胶囊
  • 气体
  • 液体

第九章 依处理程序分類的碘 131 同位素市场

  • 放射性碘消融术
  • 放射性碘治疗
  • 全身扫描

第 10 章 Iodine-131 同位素市场病患细分

  • 成人
  • 小儿科

第十一章美洲碘131同位素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太碘131同位素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲碘131同位素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-9A6A6F297712

The Iodine-131 Isotope Market was valued at USD 5.20 billion in 2023, expected to reach USD 5.52 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 8.07 billion by 2030.

Iodine-131 is a radioactive isotope extensively used in medical applications, particularly for diagnostic and therapeutic purposes in nuclear medicine. It is instrumental in the treatment of thyroid disorders, such as hyperthyroidism and certain types of thyroid cancer due to its ability to destroy tissue selectively. In the energy sector, Iodine-131 is also used as a tracer in hydraulic fracturing and diagnostics of countercurrent flow. The market for Iodine-131 is driven by the increasing prevalence of thyroid disorders globally, rising awareness and adoption of nuclear medicine, and advancements in radiopharmaceutical technology. A significant influencer of growth is the heightened investment in healthcare infrastructure and expanding geriatric population prone to thyroid conditions. Moreover, increasing demand for minimally invasive procedures contributes to the market's expansion. Recent opportunities include innovations in targeted radiopharmaceutical therapies, which can broaden the application of Iodine-131 in treating other cancer types, while improving delivery mechanisms can enhance its effectiveness and reduce side effects. However, challenges like stringent regulatory frameworks, high production costs, and the necessity for specialized handling and disposal procedures due to its radioactive nature can impede growth prospects. Limitations also arise from supply chain constraints and the need for consistent quality standards in production. To capitalize on market opportunities, developing strategic collaborations between research institutions and radiopharmaceutical companies is crucial. Areas ripe for innovation include research into novel carrier molecules for Iodine-131, improving precision in dose delivery, and expanding its application scope beyond thyroid-related conditions. The market is dynamic, characterized by rapid technological advancements and evolving therapeutic demands, which together underscore the importance of sustained research investment and regulatory compliance to maintain competitive advantage and market penetration.

KEY MARKET STATISTICS
Base Year [2023] USD 5.20 billion
Estimated Year [2024] USD 5.52 billion
Forecast Year [2030] USD 8.07 billion
CAGR (%) 6.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Iodine-131 Isotope Market

The Iodine-131 Isotope Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
    • Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
    • Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
  • Market Restraints
    • Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
  • Market Opportunities
    • Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
    • Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
    • Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
  • Market Challenges
    • Competition from alternative diagnostic and therapeutic isotopes

Porter's Five Forces: A Strategic Tool for Navigating the Iodine-131 Isotope Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Iodine-131 Isotope Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Iodine-131 Isotope Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Iodine-131 Isotope Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Iodine-131 Isotope Market

A detailed market share analysis in the Iodine-131 Isotope Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Iodine-131 Isotope Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Iodine-131 Isotope Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Iodine-131 Isotope Market

A strategic analysis of the Iodine-131 Isotope Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Iodine-131 Isotope Market, highlighting leading vendors and their innovative profiles. These include Advanced Accelerator Applications, Bayer AG, BRAHMS GmbH, Canon Medical Systems, Cardinal Health, Cardinal Health Nuclear & Precision Health Solutions, Curium, Eckert & Ziegler, GE Healthcare, IBA Radiopharma Solutions, Isotopia Molecular Imaging, Mallinckrodt Pharmaceuticals, Medtronic, Nordion, NorthStar Medical Radioisotopes, NTP Radioisotopes, Philips Healthcare, Siemens Healthineers, Smiths Medical, and ZymoGenetics.

Market Segmentation & Coverage

This research report categorizes the Iodine-131 Isotope Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Agricultural, Industrial, Medical, and Pharmaceutical. The Agricultural is further studied across Pest Control and Soil Fertility Research. The Industrial is further studied across Diagnostics and Radiation Therapy. The Medical is further studied across Hyperthyroidism Treatment, Research and Development, and Thyroid Cancer Treatment. The Pharmaceutical is further studied across Radiopharmaceuticals.
  • Based on End User, market is studied across Agricultural Sector, Hospitals and Clinics, Pharmaceutical Companies, and Research Institutes. The Hospitals and Clinics is further studied across Private Hospitals and Public Hospitals. The Research Institutes is further studied across Academic Research Institutes and Medical Research Institutes.
  • Based on Form, market is studied across Capsules, Gas, and Liquid.
  • Based on Therapeutic Procedures, market is studied across Radioactive Iodine Ablation, Radioactive Iodine Therapy, and Whole-Body Scan.
  • Based on Patient Demographics, market is studied across Adults and Pediatrics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of nuclear imaging techniques in the diagnosis and treatment of various cancers leveraging iodine-131
      • 5.1.1.2. Increased collaboration between healthcare institutions and research bodies to advance the therapeutic use of iodine-131
      • 5.1.1.3. Expansion of iodine-131 isotope applications beyond oncology into other medical fields enhancing market growth
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of advanced medical facilities and trained professionals for iodine-131 applications in developing regions
    • 5.1.3. Opportunities
      • 5.1.3.1. Investigating the potential growth of iodine-131 isotopes in veterinary medicine and animal health
      • 5.1.3.2. Evaluating the adoption of iodine-131 isotopes in thyroid disease treatment protocols across emerging markets
      • 5.1.3.3. Exploring the use of iodine-131 isotopes in innovative nuclear medicine therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Competition from alternative diagnostic and therapeutic isotopes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Iodine-131 Isotope Market, by Application

  • 6.1. Introduction
  • 6.2. Agricultural
    • 6.2.1. Pest Control
    • 6.2.2. Soil Fertility Research
  • 6.3. Industrial
    • 6.3.1. Diagnostics
    • 6.3.2. Radiation Therapy
  • 6.4. Medical
    • 6.4.1. Hyperthyroidism Treatment
    • 6.4.2. Research and Development
    • 6.4.3. Thyroid Cancer Treatment
  • 6.5. Pharmaceutical
    • 6.5.1. Radiopharmaceuticals

7. Iodine-131 Isotope Market, by End User

  • 7.1. Introduction
  • 7.2. Agricultural Sector
  • 7.3. Hospitals and Clinics
    • 7.3.1. Private Hospitals
    • 7.3.2. Public Hospitals
  • 7.4. Pharmaceutical Companies
  • 7.5. Research Institutes
    • 7.5.1. Academic Research Institutes
    • 7.5.2. Medical Research Institutes

8. Iodine-131 Isotope Market, by Form

  • 8.1. Introduction
  • 8.2. Capsules
  • 8.3. Gas
  • 8.4. Liquid

9. Iodine-131 Isotope Market, by Therapeutic Procedures

  • 9.1. Introduction
  • 9.2. Radioactive Iodine Ablation
  • 9.3. Radioactive Iodine Therapy
  • 9.4. Whole-Body Scan

10. Iodine-131 Isotope Market, by Patient Demographics

  • 10.1. Introduction
  • 10.2. Adults
  • 10.3. Pediatrics

11. Americas Iodine-131 Isotope Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Iodine-131 Isotope Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Iodine-131 Isotope Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Advanced Accelerator Applications
  • 2. Bayer AG
  • 3. BRAHMS GmbH
  • 4. Canon Medical Systems
  • 5. Cardinal Health
  • 6. Cardinal Health Nuclear & Precision Health Solutions
  • 7. Curium
  • 8. Eckert & Ziegler
  • 9. GE Healthcare
  • 10. IBA Radiopharma Solutions
  • 11. Isotopia Molecular Imaging
  • 12. Mallinckrodt Pharmaceuticals
  • 13. Medtronic
  • 14. Nordion
  • 15. NorthStar Medical Radioisotopes
  • 16. NTP Radioisotopes
  • 17. Philips Healthcare
  • 18. Siemens Healthineers
  • 19. Smiths Medical
  • 20. ZymoGenetics

LIST OF FIGURES

  • FIGURE 1. IODINE-131 ISOTOPE MARKET RESEARCH PROCESS
  • FIGURE 2. IODINE-131 ISOTOPE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. IODINE-131 ISOTOPE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. IODINE-131 ISOTOPE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IODINE-131 ISOTOPE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IODINE-131 ISOTOPE MARKET DYNAMICS
  • TABLE 7. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEST CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY SOIL FERTILITY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HYPERTHYROIDISM TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THYROID CANCER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL SECTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY WHOLE-BODY SCAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL IODINE-131 ISOTOPE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES IODINE-131 ISOTOPE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 141. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 151. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 152. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 161. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 162. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 163. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 172. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 173. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 174. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 181. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 183. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 184. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 185. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 192. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 194. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 196. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 203. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 205. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 206. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 207. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 216. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 217. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 218. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 225. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 227. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 228. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 229. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 236. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 238. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 239. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 240. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 247. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 249. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 250. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 251. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 261. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 262. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA IODINE-131 ISOTOPE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 270. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 272. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 273. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 274. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 281. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 283. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 284. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 285. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 292. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 294. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 295. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 296. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 303. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 305. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 306. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 307. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 314. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 316. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 317. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 318. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 323. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 324. GERMANY IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 325. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 327. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 328. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 329. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 330. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 331. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 332. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 333. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 334. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 335. ISRAEL IODINE-131 ISOTOPE MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 336. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 337. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
  • TABLE 338. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 339. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 340. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 341. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 342. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 343. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 344. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 345. ITALY IODINE-131 ISOTOPE MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 346. ITALY IODINE-131 ISOTOP